Regulation of immune functions by combined Jinlong capsule and interventional therapy in patients with primary liver cancer
10.3969/j.issn.1000-8179.20130206
- VernacularTitle:金龙胶囊联合介入治疗对原发性肝癌患者免疫功能调节作用的观察
- Author:
Tianwen YUAN
;
Shuwei WEN
;
Zhijun DANG
;
Xiaoqian ZHANG
;
Junping CHANG
;
Yaoqin XUE
- Publication Type:Journal Article
- Keywords:
Jinlong capsule;
combination;
interventional therapy;
primary liver cancer;
immunity
- From:
Chinese Journal of Clinical Oncology
2013;(18):1116-1118
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To determine the effects of Jinlong capsule combined with interventional therapy on the immune functions of primary hepatocellular carcinoma patients. Methods:Sixty randomly selected cases of clinically diagnosed primary hepatocellular carcinoma were divided into the observation group and the control group. Three days after operation, the observation group was given four Jinlong capsules three times a day for 30 days (one treatment). Meanwhile, the control group received interventional therapy after the operation. One to four days following one treatment, peripheral blood specimens were collected from the two groups to determine the cellular immune function indices. Results:The cell numbers (mean) of the peripheral blood components CD3, CD4, NK, SIL-2R, TSGF, and SIL-2R and the CD4/CD8 ratio in the observation group showed no significant difference before and after treatment. In the control group, these indices were significantly different before and after treatment. Conclusion:The Jinlong capsule facilitates the cellu-lar immunity recovery of patients with primary hepatocellular carcinoma after interventional therapy.
